This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Tom Krenzke
Vice President
Contact
TomKrenzke@westat.comOverview
Tom Krenzke has extensive experience in survey sampling and estimation techniques, and has led research in statistical confidentiality, sample design, non-probability sampling, small area estimation, variance estimation, imputation, and nonresponse bias. Prior to joining Westat, Krenzke worked at the U.S. Census Bureau.
Krenzke is a Fellow of the American Statistical Association (ASA) and has held several positions in ASA, including chair of the ASA Committee on Privacy and Confidentiality and program chair of the Survey Research Methods Section. He has also served as President of the Washington Statistical Society. He leads Westat’s Steering Committee on WesDaX® (Westat’s real-time online table generator) and Westat’s Confidentiality Work Group and serves on the Westat Institutional Review Board.
In recognition of his contributions to the field, Krenzke has been named a Westat Senior Statistical Fellow and serves on the Statistical Fellows Committee, which provides consultation on important survey statistics issues and addresses recent advances in applied statistics.
Education
- MS, Applied Statistics, Bowling Green State University
- BA, Mathematics, Winona State University
Areas of Expertise
Data Privacy Data Quality Statistical Methods Survey Design Survey Methods Survey Statistics-
Protection from COVID-19 mRNA vaccination and prior SARS-CoV-2 infection against COVID-19-associated encounters in adults during Delta and Omicron predominance
Journal of Infectious Diseases
January 2023
C.H. Bozio, K.A. Butterfield, M. Briggs Hagen, S. Grannis, P. Drawz, E. Hartmann, T.C. Ong, et al.
DOILink for: Protection from COVID-19 mRNA vaccination and prior SARS-CoV-2 infection against COVID-19-associated encounters in adults during Delta and Omicron predominance -
Relationships between social vulnerability and coronavirus disease 2019 vaccination coverage and vaccine effectiveness
Clinical Infectious Diseases
January 2023
A.F. Dalton, Z.A. Weber, K.S. Allen, E. Stenehjem, S.A. Irving, T.L. Spark, K. Adams, et al.
DOILink for: Relationships between social vulnerability and coronavirus disease 2019 vaccination coverage and vaccine effectiveness -
Estimation of COVID-19 mRNA vaccine effectiveness and COVID-19 illness and severity by vaccination status during Omicron BA.4 and BA.5 sublineage periods
6,
JAMA Network Open
January 2023
R. Link-Gelles, M.E. Levy, K. Natarajan, S.E. Reese, A.L. Naleway, S.J. Grannis, N.P. Klein, et al.
DOILink for: Estimation of COVID-19 mRNA vaccine effectiveness and COVID-19 illness and severity by vaccination status during Omicron BA.4 and BA.5 sublineage periods